Nevertheless, SMAD4 loss has been linked to non-canonical TGF-β signaling through the MEK/ERK and PI3K/AKT pathways,24,25 albeit no association has been described between SMAD4 loss and OS in advanced stages of pancreatic cancer.26,27. The gene discussed is AKT1; the disease is pancreatic neoplasm.